Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Geoffrey Porges
Recent news which mentions Geoffrey Porges
Pfizer Analyst Breaks Down The FDA Process For Coronavirus Vaccine Candidate
December 11, 2020
Tickers
BNTX
PFE
Tags
Analyst Color
Analyst Ratings
Market News
From
Benzinga
AstraZeneca Analyst Flags Lack Of Details In Interim COVID-19 Vaccine Data
November 23, 2020
Tickers
AZN
MRNA
PFE
Tags
BofA Securities
MRNA
News
From
Benzinga
Pfizer Analysts Raise Odds Of Success For Coronavirus Vaccine Candidate To 100%
November 10, 2020
Tickers
PFE
Tags
Market News
SVB Leerink
Benzinga
From
Benzinga
Pfizer's COVID-19 Vaccine Candidate Primed For $3.5B In 2021 Sales: Analyst
October 21, 2020
Tickers
BNTX
PFE
Tags
Analyst Ratings
Analyst Color
Benzinga
From
Benzinga
Vertex shuts down trial of liver drug, spurring a selloff
October 15, 2020
Tags
Vertex Pharmaceuticals Incorporated
Liisa Bayko
Arrowhead Pharmaceuticals, Inc/
From
Business Journals
Moderna, Pfizer Have 2-Month Lead Over Coronavirus Vaccine Competitors: Analyst
October 07, 2020
Tickers
AZN
BNTX
JNJ
MRNA
Tags
JNJ
vaccine
Coronavirus
From
Benzinga
Gilead Analysts Dissect Immunomedics Deal: 'Pricier But Bold Move Into Oncology'
September 14, 2020
Tickers
AZN
GILD
IMMU
Tags
Matthew Harrison
Price Target
Market News
From
Benzinga
Gilead Analysts Downplay Q2 Miss Amid Remdesivir's COVID-19 Opportunity
July 31, 2020
Tickers
GILD
Tags
Biotech
Cantor Fitzgerald
Health Care
From
Benzinga
Pfizer Analysts See 'Surprisingly Strong' Vaccine Updates In Q2, Question Biopharma's Blockbuster Potential
July 29, 2020
Tickers
MYL
PFE
UBS
Tags
Mizuho Securities
Geoffrey Porges
UBS
From
Benzinga
Moderna Looking To Price Its Coronavirus Vaccine At $50-$60, Significantly Above Rivals: FT
July 28, 2020
Tickers
AZN
BNTX
JNJ
MRK
Tags
NVAX
Geoffrey Porges
AZN
From
Benzinga
Moderna Analysts See Positives In Coronavirus Readout As Focus Shifts To Pivotal Phase 3 Study
July 15, 2020
Tickers
BNTX
MRNA
PFE
Tags
Health Care
Biotech
Movers
From
Benzinga
4 Analysts On Why The Rumored AstraZeneca-Gilead Deal Is Unlikely To Materialize
June 08, 2020
Tickers
ALXN
AMGN
AZN
BIIB
Tags
Salim Syed
Media
News
From
Benzinga
Will anything come of AstraZeneca's rumored interest in merging with Gilead? Not likely
June 08, 2020
Tags
Astrazeneca PLC
Roche
Kyverna Therapeutics Inc/
From
Business Journals
Will Gilead, the acquirer, be Gilead, the acquired? Not likely
June 08, 2020
Tags
Genentech
Dan O'Day
Biotech
From
Business Journals
Gilead Analyst: Coronavirus Drug, Arcus Collaboration Make Biopharma A Buy
June 03, 2020
Tickers
GILD
RCUS
Tags
Biotech
General
Geoffrey Porges
From
Benzinga
ResTorbio pivots pipeline with reverse-merger after trial failure
April 29, 2020
Tags
Health Care
Adicet Bio, Inc/
Novartis AG
From
Business Journals
Proteostatis stock plunges on cystic fibrosis triple combo data
March 25, 2019
Tags
Vertex Pharmaceuticals
Biotech
Vertex Pharmaceuticals Incorporated
From
Business Journals
Vertex says sales of cystic fibrosis drugs could hit $3B this year
July 26, 2018
Tags
Ian Smith
Pharmaceuticals
Health Care
From
Business Journals
Biogen says Alzheimer's drug slowed disease, but shares tumble on skepticism
July 25, 2018
Tags
Biogen Inc/
Biogen
Biotech
From
Business Journals
Leerink: Translate Bio's Cystic Fibrosis Candidate Could Generate $1.8B
July 23, 2018
Tickers
TBIO
Tags
Geoffrey Porges
Leerink
TBIO
From
Benzinga
Biogen shares leap as Alzheimer's drug shows potential to slow disease
July 06, 2018
Tags
Geoffrey Porges
Biogen Inc/
Biogen
From
Business Journals
Landmark Vertex cystic fibrosis drug could hit market by late 2019: analyst
February 22, 2018
Tags
Biotech
Vertex Pharmaceuticals Incorporated
Bioscience
From
Business Journals
Biogen shares plunge after company makes change to Alzheimer’s drug trials
February 14, 2018
Tags
Biotech
Merck & Co/
Biogen Inc/
From
Business Journals
AbbVie Shares Double In A Year; Leerink Moves To Sidelines
January 29, 2018
Tickers
ABBV
ALXN
CELG
REGN
Tags
VRTX
Leerink
Downgrades
From
Benzinga
Analyst names Vertex and Alexion 'top picks for 2018'
January 02, 2018
Tags
Vertex Pharmaceuticals Incorporated
Biogen
Vertex Pharmaceuticals
From
Business Journals
Plenty Of Opportunity In AbbVie, Even After Recent Run
October 02, 2017
Tickers
ABBV
AMGN
Tags
Benzinga
Price Target
AMGN
From
Benzinga
43% Upside Seen For Dova Pharma Following Competitor Product's Poor Results
September 26, 2017
Tickers
DOVA
Tags
Geoffrey Porges
Leerink
avatrombopag
From
Benzinga
Vertex’s latest FDA nod could boost sales by $150M: analyst
August 02, 2017
Tags
Biotech
Vertex Pharmaceuticals
Vertex Pharmaceuticals Incorporated
From
Business Journals
Sarepta hikes full-year sales estimate for Duchenne drug
July 19, 2017
Tags
Health Care
Sarepta Therapeutics, Inc/
Douglas Ingram
From
Business Journals
How analysts are interpreting Biogen's management shakeup
June 14, 2017
Tickers
BIIB
Tags
Salim Syed
Jean/Paul Kress
Leerink Partners
From
Business Journals
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.